Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001666 · ClinicalTrials.gov registry record
Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
A clinical trial of Seizures and Partial Epilepsy, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT00001666 is a study of Seizures and Partial Epilepsy that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 32 participants, below the 934-participant average among 39 other Seizures trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001666, a study of Seizures and Partial Epilepsy, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that can be used to stimulate brain activity and gather information about brain function. It is very useful when studying the areas of the brain related to motor activity (motor cortex, corticospinal tract, and corpus callosum). Epilepsy is a condition associated with seizures as a result of an over excitable cerebral cortex. Despite the introduction of several new antiepileptic medications, less than half of the patients diagnosed with partial epilepsy are well controlled. However, studies have shown that non-invasive stimulation of the brain can decrease the excitability of the cerebral cortex. Researchers are interested in the potential therapeutic effects of TMS on patients with epilepsy that have responded poorly to standard medication. This study will use TMS to decrease the excitability of the areas of the brain responsible for seizures.
Conditions Studied
Interventions
- DEVICE Cadwell High-Speed Magnetoelectric Stimulator
- DEVICE Magpro High-Speed Magnetoelectric Stimulator
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 1997-03 |
| Est. Completion | 2002-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001666
The ClinicalTrials.gov registry entry for NCT00001666 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 39 other Seizures trials with a reported enrollment target (97% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Seizures appearing as the primary indexed condition, and to 2 interventions - of which Cadwell High-Speed Magnetoelectric Stimulator is the first listed.
NCT00001666 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001666 about?
NCT00001666 is a clinical study titled "Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy". Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that can be used to stimulate brain activity and gather information about brain function. It is very useful when studying the areas of the brain related to motor activity (motor cortex, corticospinal tract, and corpus callosum). Ep...
What is the current status of trial NCT00001666?
This trial is currently completed. The enrollment target is 32 participants. The study started on 1997-03. Estimated completion is 2002-06.
What conditions does trial NCT00001666 study?
This clinical trial studies the following conditions: Seizures, Partial Epilepsy.
What interventions are being tested in trial NCT00001666?
The interventions under investigation include: Cadwell High-Speed Magnetoelectric Stimulator (DEVICE), Magpro High-Speed Magnetoelectric Stimulator (DEVICE).
Who is sponsoring clinical trial NCT00001666?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001666 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Modulating Movement Intention Via Cortical Stimulation
RECRUITING · NA
-
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
RECRUITING · NA
-
Oxygen Toxicity: Mechanisms in Humans
RECRUITING · NA
-
Longitudinal Study of Neurogenetic Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.